State updates plan to improve access to dementia care
By
Kimberly Bonvissuto
Feb 21, 2024
Rhode Island recently unveiled a five-year update to its state plan to improve access to dementia care as well as improve quality of life for those living with Alzheimer’s disease or another form of...
Bipartisan group pushes CMS to expand coverage for Alzheimer’s treatments
By
Kimberly Bonvissuto
Feb 21, 2023
Access to federally approved monoclonal antibody and other disease-modifying therapies for Alzheimer’s disease will be “extremely limited” unless the Centers for Medicare & Medicaid Services reconsiders...
$14.6 million study, a first, aims to combat dementia in Native, Pacific Islander communities
By
Kimberly Bonvissuto
May 24, 2023
A first-ever study will adapt Alzheimer’s tests for Indigenous communities to expand treatment and research options for dementia in those populations.
2023 proved to be a ‘landmark’ year in progress toward treatment of Alzheimer’s disease
By
Kimberly Bonvissuto
Dec 15, 2023
The 2023 update to the nation’s roadmap of strategies and actions to address Alzheimer’s disease was released Wednesday, highlighting “landmark” progress made over the past year in understanding...
$4 billion increase in Alzheimer’s funding needed to prevent ‘catastrophe,’ coalition with provider...
By
Kimberly Bonvissuto
Jul 11, 2023
Funding the national response to Alzheimer’s and related dementias is a “national priority, economic and budgetary necessity, health and moral imperative,” according to a coalition of 360 organizations...
Bill calls for $165 million in funding for Alzheimer’s-related initiatives
By
Kimberly Bonvissuto
Feb 12, 2024
Bipartisan bills recently introduced in the US Senate and House of Representatives, if passed as written and signed into law, would fund public health initiatives related to Alzheimer’s disease to the...
AI model using health records predicts Alzheimer’s disease up to 5 years before diagnosis
By
Kimberly Bonvissuto
Mar 01, 2023
A team of researchers designed an artificial intelligence system that can predict which individuals will develop Alzheimer’s disease up to five years before a diagnosis.
Promising Alzheimer’s drug results hailed as ‘major milestone’
By
Kimberly Bonvissuto
Sep 29, 2022
An investigational drug showing promise in reducing cognitive decline in early Alzheimer’s disease is being hailed as having potential to “change the course” of the disease.
Assisted living providers to face increased regulation from bill headed for governor’s signature
By
Kimberly Bonvissuto
Apr 08, 2024
A bill expected to become law and targeting assisted living reform in Arizona addresses some best practices long touted by industry experts, but it also brings an increase in regulations for providers.
Assisted living providers can take steps to address workforce shortages, quality, Alzheimer’s Association...
By
Lois A. Bowers
Apr 22, 2024
As federal lawmakers ponder ways to address workforce shortages and quality in senior living communities and other long-term care settings, the Alzheimer’s Association and its advocacy affiliate, the...